Who Owns Werewolf Therapeutics Stock?
NASDAQ: HOWLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:09 PM ET
Ownership breakdown
- Held by institutions
- 39.10%
- Held by insiders
- 6.62%
- Institutional holders
- 58
- Institutions 39.1%
- Insiders 6.6%
- Public and other 54.3%
Who owns Werewolf Therapeutics stock?
Institutional investors own about 39.1% of Werewolf Therapeutics's shares, spread across 58 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 6.62% of HOWL.
The largest institutional holders are RA Capital Management, L.P. (4.91%), Balyasny Asset Management LP (3.68%) and Vanguard Capital Management LLC (2.51%). Together, the top 10 institutions control 18.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their HOWL positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of HOWL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 2.39M | 4.91% | -64.3% |
| Balyasny Asset Management LP | 1.79M | 3.68% | +100.0% |
| Vanguard Capital Management LLC | 1.22M | 2.51% | 0.0% |
| Renaissance Technologies, LLC | 674.63K | 1.39% | +30.7% |
| Lynx1 Capital Management Lp | 657.79K | 1.35% | 0.0% |
| Sphera Funds Management Ltd. | 626.81K | 1.29% | 0.0% |
| DC Funds, LP | 589.10K | 1.21% | 0.0% |
| Verdad Advisers, LP | 348.71K | 0.72% | +1071.7% |
| Geode Capital Management, LLC | 335.81K | 0.69% | -13.8% |
| Bank of America Corporation | 311.50K | 0.64% | +17.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of HOWL
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 873.75K | 1.80% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 344.23K | 0.71% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 165.50K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 54.58K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 42.63K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 10.51K | 0.02% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 500 | 0.00% |
| Guggenheim Active Allocation Fund | 153 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Werewolf Therapeutics?
RA Capital Management, L.P. is the largest institutional shareholder of HOWL, owning 4.91% of shares outstanding (2.39M shares) as of its latest 13F filing.
What percentage of Werewolf Therapeutics is owned by institutions?
Institutions own about 39.1% of HOWL shares and 41.9% of the public float.
How much of Werewolf Therapeutics do insiders own?
Insiders, such as officers and directors, own about 6.62% of HOWL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.